Chimeric Therapeutics Limited (CHM.AX)
AUD 0.01
(-14.29%)
AUD 0.01
(-14.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 19.76 Million AUD | -30.69% |
| 2023 | 28.52 Million AUD | 65.92% |
| 2022 | 17.18 Million AUD | 15.78% |
| 2021 | 14.84 Million AUD | 23095.42% |
| 2020 | 64 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 5.72 Million AUD | -34.39% |
| 2024 FY | 20.71 Million AUD | -27.37% |
| 2024 Q2 | 8.72 Million AUD | 109.87% |
| 2024 Q1 | 4.15 Million AUD | -71.96% |
| 2024 Q4 | 16.77 Million AUD | 92.55% |
| 2023 Q1 | 7.32 Million AUD | -6.57% |
| 2023 Q2 | 14.65 Million AUD | 100.0% |
| 2023 Q4 | 14.82 Million AUD | 99.84% |
| 2023 Q3 | 7.42 Million AUD | -49.38% |
| 2023 FY | 28.52 Million AUD | 65.92% |
| 2022 Q4 | 7.84 Million AUD | 91.77% |
| 2022 Q3 | 4.09 Million AUD | -56.23% |
| 2022 Q2 | 9.34 Million AUD | 95.84% |
| 2022 Q1 | 4.77 Million AUD | -57.79% |
| 2022 FY | 17.18 Million AUD | 15.78% |
| 2021 Q4 | 11.3 Million AUD | 96.53% |
| 2021 FY | 14.84 Million AUD | 23095.42% |
| 2021 Q3 | 5.75 Million AUD | 62.36% |
| 2021 Q1 | 1.8 Million AUD | 0.0% |
| 2021 Q2 | 3.54 Million AUD | 96.64% |
| 2020 FY | 64 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 50.05% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -2683.281% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -232.307% |
| Biome Australia Limited | 7.91 Million AUD | -149.865% |
| Patrys Limited | 4.93 Million AUD | -300.691% |
| Orthocell Limited | 15.36 Million AUD | -28.614% |
| Imugene Limited | 135.09 Million AUD | 85.367% |
| Noxopharm Limited | 7 Million AUD | -182.383% |
| PYC Therapeutics Limited | 60.91 Million AUD | 67.55% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -81.372% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -2115.714% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -77.707% |
| CSL Limited | 7.56 Billion AUD | 99.739% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -83.281% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -615.945% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 36.84% |
| Starpharma Holdings Limited | 22.81 Million AUD | 13.362% |
| Nanollose Limited | 12.5 Thousand AUD | -158026.022% |
| Memphasys Limited | 3.67 Million AUD | -437.392% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -490.796% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -905.858% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -134.329% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -3184.592% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -379.167% |
| Race Oncology Limited | 14.77 Million AUD | -33.83% |
| Nyrada Inc. | 4.55 Million AUD | -333.954% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 92.659% |
| Dimerix Limited | 25.64 Million AUD | 22.914% |
| PharmAust Limited | 6.65 Million AUD | -196.941% |
| Immutep Limited | 42.87 Million AUD | 53.896% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 64.894% |
| Alterity Therapeutics Limited | 23.4 Million AUD | 15.548% |
| BTC Health Limited | -1.03 Million AUD | 2002.668% |
| Acrux Limited | 8.55 Million AUD | -131.197% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 39.544% |
| Biotron Limited | 5.11 Million AUD | -286.785% |
| Tissue Repair Ltd | 6.66 Million AUD | -196.504% |
| AdAlta Limited | 6.76 Million AUD | -192.005% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -6506.111% |
| Hexima Limited | 1 Million AUD | -1859.587% |
| AnteoTech Limited | 12.18 Million AUD | -62.2% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 69.637% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | 8.841% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -334.887% |
| Actinogen Medical Limited | 22.77 Million AUD | 13.189% |
| Immuron Limited | 9.13 Million AUD | -116.322% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -139.049% |